Tateaki Naito

Cumulative incidence of and predictive factors for lung cancer in IPF

Yuichi Ozawa, Takafumi Suda, Tateaki Naito et al. · Respirology · 2009 · 320 citations

Medicine, Oncology, Cancer Epidemiology +15

Anamorelin (ONO‐7643) for the treatment of patients with non–small cell lung cancer and cachexia: Results from a randomized, double‐blind, placebo‐controlled, multicenter study of Japanese patients (ONO‐7643‐04)

Nobuyuki Katakami, Junji Uchino, Takuma Yokoyama et al. · Cancer · 2017 · 243 citations · Full text

Medicine, Oncology, Pharmacology +16

Ponsegromab for the Treatment of Cancer Cachexia

John D. Groarke, Jeffrey Crawford, Susie M. Collins et al. · New England Journal of Medicine · 2024 · 240 citations · Full text

Medicine, Oncology, Pharmacology +13

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

Takafumi Suda, Yusuke Kaida, Yutaro Nakamura et al. · Respiratory Medicine · 2009 · 229 citations · Full text

Medicine, Immunology, Internal Medicine +15

The Risk of Cytotoxic Chemotherapy-Related Exacerbation of Interstitial Lung Disease with Lung Cancer

Hirotsugu Kenmotsu, Tateaki Naito, Madoka Kimura et al. · Journal of Thoracic Oncology · 2011 · 228 citations · Full text

Medicine, Oncology, Pharmacology +16